neratinib plus fulvestrant for her2 mutant, non-amplified metastatic breast cancer
Published 2 years ago • 46 plays • Length 7:30Download video MP4
Download video MP3
Similar videos
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
21:00
gs4 10 neratinib fulvestrant trastuzumab for hormone receptor-positive, her2-mutant metastatic
-
4:52
neratinib fulvestrant trastuzumab for hr her2-mutant mbc and neratinib trastuzumab for tr...
-
6:20
fulvestrant and palbociclib as first-line treatment for hr /her2- breast cancer
-
6:46
neratinib in mbc with her2 activating mutations
-
4:37
neratinib-based combination therapy in her2-mutant lung cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
7:49
asco: alpelisib plus fulvestrant for pik3ca-mutated breast cancer after failure of cdk4/6 inhibitors
-
2:21
trastuzumab deruxtecan for her2-mutated metastatic nsclc
-
5:33
capecitabine plus either neratinib or lapatinib for patients with her2 breast cancer
-
3:11
neratinib prophylaxis in her2 metastatic breast cancer
-
3:15
neratinib for metastatic breast cancer
-
3:27
alpelisib plus fulvestrant for hormone receptor positive metastatic breast cancer
-
44:21
2023 updates in metastatic breast cancer treatment
-
1:20
final results from the phase 2 summit basket trial: targeting her2 advanced btcs with neratinib
-
2:00
neratinib after trastuzumab-based adjuvant therapy in her 2 positive breast cancer (extenet)
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
9:35
neratinib in her2 breast cancer
-
5:20
novel approaches for her2-negative metastatic breast cancer